Tildacerfont |
| カタログ番号GC65893 |
Tildacerfont は、強力で経口的に活性な副腎皮質刺激ホルモン放出因子 1 型 (CRF1) 受容体拮抗薬です。 Tildacerfont は、副腎皮質刺激ホルモン (ACTH) と副腎アンドロゲンのレベルを効果的に低下させます。 Tildacerfont の安全性プロファイルは良好です。 Tildacerfont は、先天性副腎過形成の研究に使用できます。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1014983-00-6
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Tildacerfont is a potent and orally active corticotrophin-releasing factor type 1 (CRF1) receptort antagonis. Tildacerfont effectively reduces adrenocorticotropic hormone (ACTH) and adrenal androgen levels. Tildacerfont has favourable safety profile. Tildacerfont can be used for researching congenital adrenal hyperplasia[1].
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *